Chromatin remodelling and actin organisation  by Farrants, Ann-Kristin Östlund
FEBS Letters 582 (2008) 2041–2050Minireview
Chromatin remodelling and actin organisation
Ann-Kristin O¨stlund Farrants*
Department of Cell Biology, The Wenner-Gren Institute, The Arrhenius Laboratories F4, Stockholm University, SE-106 91 Stockholm, Sweden
Received 11 March 2008; revised 15 April 2008; accepted 21 April 2008
Available online 28 April 2008
Edited by Christos StournarasAbstract Chromatin remodelling is a prerequisite for nuclear
processes, and cells have several diﬀerent ways of remodelling
the chromatin structure. The ATP-dependent chromatin remod-
elling complexes are large multiprotein complexes that use ATP
to change DNA–histone contacts. These complexes are classiﬁed
into 4 sub-families depending on the central ATPase. The switch
mating type/sucrose non-fermenting (SWI/SNF) complexes are
mainly involved in transcriptional regulation, and this means that
they are involved in many processes, such as the formation of ac-
tin ﬁlaments in the cytoplasm. SWI/SNF complexes are involved
in the regulation of genes expressing cell adhesion proteins and
extracellular matrix proteins. Actin is also present in the nu-
cleus, aﬀecting transcription, RNA processing and export. In
addition, actin and actin-related proteins are subunits of SWI/
SNF complexes and the INO80-containing complexes, another
subfamily of ATP-dependent chromatin remodelling complexes.
Not all functions of the actin and actin-related proteins in the
complexes are yet clear: it is known that they play important
roles in maintaining the stability of the proteins, possibly by
bridging subunits and recruiting the complexes to chromatin.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The DNA in eukaryotic chromosomes is organised with pro-
teins to form a structure called chromatin. In order for pro-
cesses that need access to the DNA to proceed, the
chromatin structure needs to be altered [for review see [1]].
The major targets in the remodelling process are the nucleo-
somes, which constitute the smallest unit in the chromatin
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doi:10.1016/j.febslet.2008.04.032around which 146 bp of DNA is wrapped, and alterations in
the interactions between DNA and histones, together with
the recruitment of nuclear proteins, cause changes in the chro-
matin structure. These changes in chromatin are the result of
two activities: the histone-modifying enzymes, which alter the
histone tails post-translationally, and the ATP-dependent
chromatin remodelling complexes, which use the energy from
ATP to change the DNA–histone contacts and induce sliding
or bulking of DNA in nucleosomes [2,3]. Both of these modes
of activity are involved in transcriptional activation, transcrip-
tional repression, replication, recombination and DNA repair,
and they are involved in the formation of heterochromatin at
speciﬁc chromosome regions.1.1. Histone-modifying enzymes and ATP-dependent chromatin
remodelling
The histone tails can have several diﬀerent kinds of post-
translational modiﬁcation: acetylation, methylation, phos-
phorylation, ubiquitinylation, sumolation, and ribosylation
[2]. These modiﬁcations occur at speciﬁc sites on the histone
tails, and several enzymes have the same activity. Acetylation
of histone tails is linked to increased accessibility of the
DNA and occurs in active genes. The speciﬁc histone acetyl-
transferases (HATs) are recruited to the genes by gene-speciﬁc
transcription factors and by other histone modiﬁcations. The
result of methylation is more diverse – it occurs both in active
genes and in heterochromatic regions, depending on the site of
methylation on the histone tail. Speciﬁc histone methyl trans-
ferases methylate the diﬀerent sites on the histones and operate
in diﬀerent regions of the chromosome, recruited by factors or
by non-structural RNA [2].
The ATP-dependent chromatin remodelling complexes can
be classiﬁed into at least four diﬀerent families depending on
the central ATPase: SWI/SNF (or BRG1/BRM associated fac-
tor (BAF) complexes) with a SWI2/SNF2 ATPase, ISWI-com-
plexes with an ISWI-ATPase, Mi-2 with a chromodomain-
helicase-DNA binding protein (CHD) as ATPase, and the
INO80 family [1]. The ATPases are conserved across evolu-
tion, as are the binding partners of the complexes and their
functions. Several other ATPases that belong to the same fam-
ily have been found in most species, but these have not been
characterised in full. Each cell contains several complexes,
and although all of the complexes characterised so far are in-
volved in transcription, they also are involved in other nuclear
processes: switch mating type/sucrose non-fermenting (SWI/
SNF) complexes are mainly involved in transcription, ISWI-
complexes in replication and transcription, Mi-2 complexes
in transcriptional repression, and INO80 type complexes inblished by Elsevier B.V. All rights reserved.
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acts simultaneously on the same genes or regions as those on
which post-translational histone-modifying enzymes act [1,2].
Many of the isolated complexes contain actin and actin-related
proteins, and these proteins are thought to be true subunits of
the complexes [4]. Here, I will discuss two diﬀerent aspects of
the role of actin and actin-related proteins (ARPs) in chroma-
tin: the eﬀect of ATP-dependent chromatin remodelling com-
plexes on actin ﬁlament organisation in the cytoplasm, and
the role of actin and ARPs in chromatin remodelling com-
plexes during transcription and DNA repair.
1.2. The SWI/SNF complexes
SWI/SNF complexes function as global gene regulators,
altering the chromatin structure and changing the accessibility
of DNA. Two types of SWI/SNF complex have been isolated
from yeast, the RSC (remodels the structure of chromatin) and
the SWI/SNF complexes, with two diﬀerent ATPases, STH1
and SWI2/SNF2, respectively [5]. These complexes consist of
12–15 subunits, which are homologous. The SWI/SNF is in-
volved in transcriptional regulation of a subset of genes [5],
whereas the role of the RSC complex is less clear, since it con-
tains proteins coded by essential genes. Mammalian cells have
two ATPases: the brahma-related gene (BRG1) and the mam-
malian brahma (BRM), which are components of two diﬀerent
forms of SWI/SNF complex [5]. The ATPases are 86% similar
and many functions are redundant. However, they also exhibit
speciﬁcity: BRG1 works with zinc-ﬁnger proteins whereas
BRM works with ankyrin proteins. The other 7–12 subunits
are shared, but preferential constellations are present in cells.
At least two diﬀerent constellations have been puriﬁed bio-
chemically, the BRG1-speciﬁc PBAF and the BAF complexes.
Two complexes, BAP and PBAP, have been isolated from Dro-
sophila, although only one ATPase exists, Brahma [5].2. Chromatin remodelling and actin ﬁlament organisation
2.1. The eﬀect of SWI/SNF on the actin ﬁlament system in
mammalian cells
Many tumours and tumour cell lines are deﬁcient in SWI/
SNF components, most often the ATPases BRG1 and BRM
[6,7]. Reintroducing the missing subunit restores SWI/SNF
activity and results in cell cycle arrest, often accompanied by
morphological changes, such as ﬂat cell formation [8]. BRG1
extopically expressed in the adrenal adenocarcinoma cell line
SW13, which is deﬁcient in both BRG1 and BRM, induces a
change in cell morphology, and actin bundles that resemble
stress-ﬁbres in ﬁbroblasts form in the cytoplasm [9]. The state
of the actin ﬁlament system is tightly regulated by several sig-
nalling pathways, actin regulatory proteins, and cell adhesion
molecules [for review see [10] and Section 1, this issue]. In
ﬁbroblasts, growth factors and other signalling molecules in-
duce the formation of stress-ﬁbres, lamellae and ﬁlopodia by
activating the small GTPases RhoA, Rac and cdc42, respec-
tively (see Section XX in this issue). The activity level of RhoA
(RhoA-GTP), however, does not change in BRG1-expressing
SW13 cells [9]. Instead, these cells have an increased level of
the Rho eﬀector molecule ROCK1, which works down-stream
of the RhoA-GTPase. The increased level of ROCK1 protein
results in a changed balance between the two RhoA eﬀector
proteins ROCK (Rho kinase) and Dia, which both contributeto the actin ﬁlament organisation [11]. BRG1expression also
increases the cell surface receptor CD44 in SW13 cells [12],
which may further promote the formation of actin ﬁlament
bundles. Microarray studies of the expression pattern in
BRG1-expressing SW13 cells show that the levels of actin-
binding protein mRNAs, such as the mRNA for transgelin,
are upregulated [13]. However, overexpressing transgelin did
not cause actin bundles to be formed in SW13 cells (P. Asp
and A-K. O¨stlund Farrants, unpublished results). The expres-
sion levels of 80 genes change on BRG1 expression; many of
these genes code for cell surface proteins [13].
The BRG1 protein introduced into another cell line that is
deﬁcient in BRG1 and BRM, the breast cancer cell line ALAB,
causes cell cycle arrest and the formation of ﬂat cells [14]. Sim-
ilar changes in the actin ﬁlament system to those observed in
SW13 cells take place also in ALAB cells upon BRG1 expres-
sion (P. Asp and A-K. O¨stlund Farrants, unpublished results).
Microarrays from BRG1-expressing ALAB cells show that the
expressions of actin regulatory proteins such as tropomyosin,
osteonectin/SPARC, moesin and a-actinin are up-regulated
rather quickly, and that the expression levels of many cell
adhesion proteins and extracellular matrix interacting proteins
are changed [14]. These changes may contribute to the change
in cell morphology that occurs on BRG1 expression. In con-
trast, BRG1 knock-down in a pancreatic tumour cell line, Mia-
PaCa2, causes a morphological change to ﬂat cells associated
with an increase in actin stress-ﬁbre-like structures [15]. The
discrepancy between the eﬀects in SW13 cells and those in Mia-
PACa2 cells may be due to diﬀerences between the cell types:
one diﬀerence being that SW13 has a disturbed retinoblastoma
(Rb) pathway and mutated p53 [16], while MiaPaCa2 has dis-
ruptions in the Rb pathway, p53-pathway and an activated ras
pathway [15]. Cross-talk between ras and Rho-signalling path-
ways does take place [17], and diﬀerent states of the ras path-
way in the SW13 and MiaPAC2a cells create diﬀerent cell
signalling contexts that may aﬀect the response to BRG1
expression.
The eﬀect of BRG1 on cell morphology has also been inves-
tigated in ﬁbroblasts stably expressing dominant-negative
BRG1 [18]. These cells are larger than the parental ﬁbroblasts,
and the morphological changes are accompanied by an in-
crease in paxillin-containing focal adhesion points, whereas
the number of stress-ﬁbres remains the same. The levels of
other adhesion proteins, such as integrins and urokinase-type
plasminogens, are also changed in these ﬁbroblasts; however,
these changes do not always take place at the mRNA level.
The mechanism may be similar to that in BRG1 expressing
SW13 cells. The increase in ROCK seen in BRG1 expressing
SW13 cells may be a result of a reduced degradation by the
proteasome, since the formation of stress-ﬁbre like actin ﬁla-
ment bundles is mimicked by protease inhibitors (P. Asp and
A-K O¨stlund Farrants, unpublished results).
Other SWI/SNF subunits than the SWI/SNF ATPases
BRG1 and BRM also aﬀect the cell morphology. When the
SWI/SNF core subunit INI1/SNF5, which is directly linked
to rhabdoid tumour development [7], is introduced into
INI1-deﬁcient MON cells, a change in morphology occurs:
the cells become rounder and loose stress-ﬁbres [19]. Similar
to the ALAB microarray experiment, changes in expression
patterns upon INI1 expression are observed in focal contact
proteins, extracellular matrix proteins and cytoskeleton pro-
teins. Paxillin-containing focal adherence also decreases in
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these genes is several days, however, suggesting that these
are indirect targets. Signal transduction pathway proteins,
such as the cytokine pathway, the Notch pathway and the
Wnt pathway, are induced early, and, therefore, more likely
candidates for direct target-genes. A further SWI/SNF sub-
unit, BAF57, causes ﬂat cell formation when introduced into
BAF57-deﬁcient cells, but no further studies of the actin ﬁla-
ment organisation have been conducted [20]. Nevertheless,
these studies further emphasise that the whole SWI/SNF com-
plex functions in the regulation of cell architecture. Despite the
variety inmorphological response to SWI/SNFdefects, these re-
sults allow us to conclude that SWI/SNF complexes are impor-
tant for maintaining the proper levels, both directly and
indirectly, of signallingmolecules, actin regulatory proteins, cell
adhesion proteins and proteins that interact with the extracellu-
lar matrix. SWI/SNF aﬀects their expression levels, and possibly
also their rates of degradation, in cell-speciﬁcways. On the other
hand, BRG1 binds to actin directly, in the C-terminal part, and
promotes actin ﬁlament polymerisation in vitro [21]. Whether
this activity is physiologically important for the formation of ac-
tin ﬁlaments in the cytoplasm remains to be seen. BRG1 and
BRM are found exclusively in the nucleus, which makes it unli-
kely that they are involved in actin ﬁlament formation in the
cytoplasm. Nevertheless, this activity may have relevance in
the nucleus, which will be discussed below.
2.2. The eﬀect of SWI/SNF on actin ﬁlament organisation in
yeast
The functional conservation between ATP-dependent chro-
matin remodelling complexes in eukaryotic cells is illustrated
by the fact that SWI/SNF complexes in yeast are involved in ac-
tin ﬁlament organisation. Microarrays of swi2 (deletion of the
ATPase) cells showed that SWI/SNF deﬁciency reduces the
expression levels of tropomyosin and of other actin regulatory
proteins [22,23]. These cells grow slowly, but their morphology
is not severely modiﬁed. On the other hand, temperature-sensi-
tive mutants in the other SWI/SNF-type complex, the yeast
RSC-complex, cause changes in cell architecture, with defects
in the actin ﬁlament organisation and sensitivity to microtu-
bule-destabilising agents [24]. No cortical actin cables are
formed in RSC-temperature-sensitive mutants at high tempera-
ture; instead actin lumps are spread in the cytoplasm, anddefects
occur in the formation of mating projection. The cause for this
defect in actin ﬁlament organisation is found in the protein ki-
nase C (PKC) signal transduction pathway and it has been sug-
gested that RSC aﬀects the expressions of genes that code for
components of the pathway. Complexes from the SWI/SNF
family regulate the actin ﬁlament system, although the types of
gene that are regulated seem to be diﬀerent. To this end, it is wor-
thy of note that the PKC pathway is responsible for the binding
of SWI/SNF to and remodelling of chromatin following signal-
ling during T-cell activation [25].
2.3. The eﬀect of SWI/SNF on the regulation of actin
cytoskeleton genes
The organisation of the actin ﬁlament system in cells is
highly dynamic, and controlled by environmental stimuli that
activate signalling pathways and actin-regulatory proteins. The
signalling pathways, mainly Rho-pathways, responsible for
regulating the actin cytoskeleton induce the formation of
stress-ﬁbres, lamellae and ﬁlopodia in the cytoplasm and geneexpression in the nucleus [10]. This couples cellular architec-
ture to transcriptional regulation, and evidence has emerged
that the link is conferred by actin and actin regulatory pro-
teins, sensing the state of the actin ﬁlament system and there-
after regulating the transcription of genes involved in actin
dynamics. In the nucleus, the transcription factor SRF (serum
response factor) is central in the response and controls the acti-
vation of actin cytoskeletal genes on Rho stimulation [re-
viewed in [26]]. Many signalling transduction pathways
converge on SRF; these pathways are activated by the MAP
kinase pathway, Rho-GTPases, and cell–cell contacts and reg-
ulate early immediate genes, such as c-fos and c-egr1, actin reg-
ulatory genes, such as vinculin and tropomyosin, and genes
speciﬁc to smooth muscle, such as telokin and SM22/transg-
elin, in response to diﬀerent signalling pathways. Interestingly,
the groups of genes regulated by SRF and SWI/SNF are sim-
ilar [26], and it is possible that some SRF-regulated genes re-
quire SWI/SNF for proper activity. Not all SRF target genes
are SWI/SNF-dependent, ruling out the simple explanation
that SRF-mediated expression requires SWI/SNF.
The speciﬁcity in the genes activated by SRF in response to
various signalling pathways is conferred by interactions with
diﬀerent co-regulators: skeletal muscle diﬀerentiation genes
with the transcription factor MyoD, cardiac diﬀerentiation
genes by GATA4, with myocardin for genes involved in
smooth muscle diﬀerentiation, and with TCR for genes in cell
growth [26]. In addition, SRF, together with the transcription
factor MAL/MRTF-A/MKL1/BSAC protein, regulates actin
cytoskeletal genes. The state of the actin ﬁlament system is
sensed by megakaryocytic acute leukemia (MAL), directly
binding monomeric actin. MAL is cytoplasmic at high mono-
meric actin concentrations and accumulates in the nucleus fol-
lowing stimuli that cause actin ﬁlaments to form [27].
Vartianinen et al. [28] have recently shown that the mechanism
behind the nuclear accumulation is inhibition of MAL nuclear
export at low actin levels, and this results in accumulation of
MAL in the nucleus and a subsequent gene activation of actin
cytoskeletal genes [27,28]. These results suggest that the cyto-
plasmic and the nuclear state of actin reﬂect each other. The
accumulation of MAL in the nucleus as such is not suﬃcient
for gene activation, since MAL associated to actin binds
SRF at the promoter region without inducing transcription
[27,28]. It is probable that MAL-actin instead recruits repres-
sors or inhibits the recruitment of activators. MAL–SRF, with
or without associated actin, does not require BRG1 or SWI/
SNF for gene activation of cytoskeletal genes. However, a re-
cent study shows that BRG1 interacts directly with MAL, and
is required for the activation of smooth muscle genes regulated
by MAL–SRF [29]. The authors suggest a model in which
BRG1 is required for the binding of SRF to low aﬃnity
MAL–SRF binding sites (smooth muscle speciﬁc genes), but
not for the binding of SRF to promoter regions with high
aﬃnity binding sites [29]. This means that SRF speciﬁcity de-
pends on the DNA sequence of response elements and the
chromatin environment at the diﬀerent types of gene. This
has already been shown for SRF–TCF-dependent genes regu-
lated by the MAP kinase pathway, since these genes are regu-
lated by SRF–ETS response elements [26]. Taken together,
mammalian SWI/SNF complexes are not involved in gene acti-
vation coupled to changes in the actin ﬁlament organisation
mediated by SRF, while they are involved in the activation
of SRF-controlled genes in the development of muscle cells.
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3.1. SWI/SNF complexes in proliferation and diﬀerentiation
SWI/SNF complexes that contain BRG1 and BRM are in-
volved in controlling? the expression of genes required for pro-
liferation and diﬀerentiation [1,5]. The expression patterns of
the two mammalian ATPases BRG1 and BRM suggest that
BRG1-containing complexes inﬂuence proliferation and
BRM complexes diﬀerentiation [30,31]. SWI/SNF complexes
of both the BRG1 and BRM type are closely connected to cell
cycle regulation, and both BRG1 and BRM are suggested to
be tumour suppressor genes [6,7,31]. Both ATPases cause cell
cycle arrest in BRG1/BRM-deﬁcient cell lines, and this has
been linked to a reactivation of the Rb pathway on restoring
the SWI/SNF activity [8]. Other subunits are also missing in
many tumour cell lines, suggesting that the complete SWI/
SNF complex operates in cell cycle control. However, recent
studies of heterozygote BRG1 knock-out mice, and compari-
son of these with SNF5 knock-out mice, show that there are
no genetic links between the Rb pathway and BRG1 and
SNF5 [32]. Other studies have also shown that the two SWI/
SNF subunits exhibit diﬀerences in cancer development, such
as the eﬀect on genetic stability [32,33], suggesting that SWI/
SNF subunits act independently of the SWI/SNF complex or
that certain subunits are required at speciﬁc genes to allow
for the correct contacts between chromatin components and
transcription factors.
3.2. SWI/SNF complexes in development
Chromatin remodelling events are a prerequisite for devel-
opment, and in particular, the SWI/SNF complexes are in-
volved in the expression of tissue-speciﬁc genes. SWI/SNF
complexes are implicated in the development of early erythro-
cytes [34], the cardiac tissue [35,36], hepatocytes [30], the neu-
ral plate [37], and skin [38]. BRG1 is essential also in an
uncharacterised early step in embryogenesis, since BRG1-null
embryos die during preimplantation [39]. This is similar to
the case for INI1-null embryos, which also die at the preim-
plantation step [40]. BAF155 is another SWI/SNF core subunit
that has been knocked out in mice, and these mice survive the
preimplantation stage but die shortly after with neurological
defects [41]. BRM-null mice, on the other hand, are viable,
healthy but larger than normal [42]. These ﬁndings suggest that
complete BRG1-containing SWI/SNF complexes are essential
in the early steps of embryogenesis. This is also reﬂected in
the temporal expression of BRM, which is reduced in early em-
bryos, but returns in many diﬀerentiating cells [30]. The devel-
opment of early erythrocytes and vascular cells in extra-
embryonic tissue are two early processes in embryogenesis that
rely exclusively on the presence of BRG1, and this fact could
explain the diﬀerence in survival between BRG1 and BRM
knock-out mice [34]. It is not clear why BRG1 is required
for these processes, but one explanation is that the expressions
of the b-globin genes depend exclusively on BRG1-containing
complexes [43]. The reason for this selectivity is not on the level
of ATPase activity, since cells expressing a BRG1 protein mu-
tated at positions close to the ATPase,without aﬀecting the
ATPase activity, exhibited a severely reduced chromatin
remodelling over the b-globin locus [43]. The locus displayed
a low level of histone acetylation and a high level of DNA
methylation, suggesting that the important function ofBRG1 is to recruit HATs and DNA-methyl transferases, and
not in remodelling nucleosomes.
BRG1 is not essential later in development, nor is it essential
for cell survival. BRG1-null ﬁbroblasts are viable, as are cells
that are deﬁcient in INI1 or BAF155, but they are more prone
to be transformed into cancer cells [39–41]. BRG1 and BRM,
as well as other subunits (sometimes even various isoforms),
vary in their expression patterns, both in time and in a cell-spe-
ciﬁc manner. These ﬁndings suggest that a shift in the compo-
sition of SWI/SNF complexes occurs during development,
giving complexes with diﬀerent speciﬁcities [44,45]. SWI/SNF
complexes with diﬀerent speciﬁcities are found in neural devel-
opment, where neural-speciﬁc isoforms of the subunits BAF53
and BAF45 are recruited to neural genes, most likely by these
neural-speciﬁc isoforms [44,45]. Similarly, there are three dif-
ferent isoforms of BAF60, two of which are expressed in a tis-
sue-speciﬁc manner [36]. Other subunits that change
expression pattern during development are BAF155, BAF170
and isoforms of the BAF250, changes that are correlated with
decisions between proliferation and diﬀerentiation [46]. Fur-
thermore, SWI/SNF complexes that contain BRG1 are in-
volved in the diﬀerentiation of adipose cells and muscle cells
[47–50]. BRG1 is responsible for the induction of skeletal mus-
cle, where the expressions of muscle-speciﬁc genes, such as the
early myogenic gene myogenin, and the late myogenic genes
desmin and muscle creatin kinase, depend on the chromatin
remodelling activity of SWI/SNF complexes [48,49]. In addi-
tion, both smooth muscle and cardiac muscle diﬀerentiation
require BRG1 for the expression of genes speciﬁc to smooth
muscle [29,50]. BRG1 binds to MAL directly during smooth
muscle diﬀerentiation, and aids the association of SRF with
weak response elements at muscle speciﬁc genes [29]. In cardiac
myocyte diﬀerentiation, LIM-only co-factors, CRP1 and
CRP2, function with SRF–GATA4 to induce genes speciﬁc
to smooth muscle, a process that also requires BRG1 [50].
BRG1 is involved also in determining the morphology of the
heart, where it inﬂuences the expression of extracellular matrix
proteins [34].
One of the major events during embryonic morphogenesis is
the epithelial–mesenchyme transition (EMT), in which the ac-
tin ﬁlament is reorganised, focal adhesions points are formed,
and the cells become more motile (reviewed in [51]). Some
parts of this programme, and the reverse mesenchyme–epithe-
lial transition, are mimicked in tumour transformation and
metastasis [51]. It is tempting to link these developmental steps
to the action of SWI/SNF complexes, in particular, since these
complexes are involved in cancer development, and they aﬀect
the actin ﬁlament by the expression of cell adhesion proteins
and cell–cell contact proteins. One event that promotes mesen-
chyme formation is mediated by Ca2+ and Rac-GTPase [52].
Loss of epithelial cell–cell contact, via the E-cadherin junction,
is followed by induction of SRF–MAL-mediated transcrip-
tional activation of vinculin and the mesenchyme marker a-ac-
tin. Despite the fact that the SWI/SNF complexes are required
for activation of some MAL–SRF target genes, these com-
plexes have not been implicated in the EMT. Instead, a sub-
unit, MTS3, of the Mi-2-containing NURD complex [53] is
required for the transition. BRG1 over-expression in mesen-
chyme stem cells leads to diﬀerentiation and apoptosis [54].
These ﬁndings suggest that SWI/SNF complexes, at least at
high levels, are incompatible with maintaining mesenchyme
cells undiﬀerentiated, a process important in self-renewal of
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complexes containing the ATPase ISWI [54]. Instead, BRG1
may be involved in diﬀerentiation event, for instance in the for-
mation of epithelial–mesenchymal interactions in limb pattern-
ing that occur in late steps in ectodermal development, most
probably by regulating genes for cell adhesion proteins [38].4. Chromatin remodelling and actin
Actin is present not only in the cytoplasm: it has also been
found in the nucleus, associated with soluble proteins and with
nuclear structures (described in Section 10, this issue). Early
studies showed that actin in the nucleus is involved in tran-
scription, but concerns were raised that the nuclear pool of ac-
tin was a result of cytoplasmic contamination. In recent years,
however, an interest in nuclear actin has emerged and actin is
now ascribed many functions in the nucleus – in transcription,
in RNA processing and in mRNA export [for reviews see
[55,56]]. Actin appears to activate transcription by all three
RNA polymerases present in eukaryotic cells, and it has, there-
fore, been suggested that it is an integral part of both initiating
and elongating polymerases. It has been suggested that actin
interacts with one of the common subunits, RPABC2 or
RPABC3, as well as indirectly associates with the CTD of
RNA polymerase II for reviews see [55,56]. Actin participates
not only in transcription bound to RNA polymerases, it also
recruits a HAT, P2D10, during transcriptional elongation
when bound directly or indirectly to the growing RNA [57].
It is still not known, however, what form of actin is involved
in transcription, and both monomeric G-actin [28] and tran-
sient polymeric actin forms are present in the nucleus [58].
The isoform that seems to be predominant in the nucleus isFig. 1. Comparison of the constellations of chromatin remodelling complex
complexes for which it is unclear whether actin is a subunit are labelled ‘‘a
activities corresponding to the yeast SWR1 and NuA4, and the ATPase is in
ATM-like protein is indicated by Tra/TRRAP. The references to the puriﬁcb-actin, although many studies have not discriminated between
isoforms.
4.1. Actin and the ISWI-containing chromatin remodelling
complexes
Actin, together with nuclear ARPs, is present in chromatin
remodelling complexes from yeast, Drosophila and mammalian
cells (and most probably plants) (for reviews see [5,59])
(Fig. 1). ARPs are related to actin, sharing the actin fold
and, in some cases, also having ATPase activity [59]. Only
SWI/SNF complexes and the INO80 family of complexes of
the four ATP-dependent chromatin remodelling families char-
acterised have actin and ARPs as subunits that are bound di-
rectly. However, one ISWI-containing complex, B-WICH,
contains nuclear myosin 1 (NM1), which interacts with actin
at the ribosomal genes in the nucleolus [60]. Based on the pres-
ence of NM1 and actin along the RNA polymerase I genes, Ye
et al. [61] proposed a model where these proteins constitute an
actomyosin molecular motor for transcriptional elongation.
NM1 associates with chromatin, forming a ‘‘track’’ with which
transient, dynamic actin ﬁlaments associated with RNA poly-
merase I interact, resulting in the two motor proteins pulling
the polymerase forwards. Ye et al. [61] used cells that expressed
mutant forms of NM1, and only the NM1 mutants that were
defective in motor activity failed to interact with RNA poly-
merase I, and subsequently the RNA polymerase I association
with chromatin in the coding region was reduced. The role of
polymeric actin in transcription was shown by expressing actin
mutant in cells inhibited for RNA polymerase I transcription
by speciﬁc antibodies. Only actin mutants that stabilised poly-
meric actin restored transcription. Furthermore, actin-dep-
olymerising drugs, such as latrunculin B and cytochalasin D,
also inhibit RNA polymerase I transcription, both in vivoes in mammalian cells, Drosophila, and Saccharomyces cerevisiae. The
ctin?’’. In mammalian cells and Drosophila, Tip60/TRRAP have both
dicated by a turquoise colour (SWR1, SRCAP, p400 or Domino). The
ations are given in the text.
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can be applied to RNA polymerase III transcription, to which
B-WICH with NM1 also associates [62]. However, B-WICH is
not found at all RNA polymerase III genes, whereas actin is a
part of the RNA polymerase III. Actin must be involved in an-
other mechanism on the promoters devoid of NM1. Actin,
which changes conformation upon ATP-hydrolysis, may in-
stead operate by functioning as a molecular switch, changing
conformation – and therefore interaction partners – between
transcriptional initiation and elongation, as well as during
elongation discussed in [63].4.2. Actin in the SWI/SNF family of chromatin remodelling
complexes
The yeast SWI/SNF and RSC complexes contain two nu-
clear ARPs, ARP7 and ARP9, whereas the mammalian and
Drosophila complexes contain the ARP4 orthologue BAF53
(BAP55), sometimes with actin [1,5]. The ARP7 and Arp9
do not have ATPase activity, but are necessary for stabilising
the yeast complexes [5,59]. Similarly, the function of BAF53
in SWI/SNF complexes is to maintain the integrity of the
mammalian complexes [5]. The function of actin in the mam-
malian complexes is to stabilise the ATPase activity of the
BRG1, and to bind SWI/SNF to nuclear structures [25].
SWI/SNF complexes are mainly involved in transcriptional
regulation by RNA polymerase II, but these complexes also
play a role in DNA repair, most likely by a similar mecha-
nism. It is possible that actin in SWI/SNF complexes plays
a similar role to the one it plays in RNA polymerase I tran-
scription described above [61]. BRG1 may bind to actin ﬁla-
ments directly in a phosphinositol-dependent manner, similar
to the in vitro [21] which may result in short ﬁlaments asso-
ciating SWI/SNF to the RNA polymerases during transcripi-
on. It is also possible that actin ﬁlaments anchor SWI/SNF
complexes to chromatin at RNA polymerase II genes. How-
ever, many preparations of SWI/SNF complexes are devoid
of actin, whereas BAF53 is present in all SWI/SNF forms.
It is diﬃcult to know the reason for this discrepancy in actin
association between preparations. In our hands, actin does
not co-purify with BRG1 and other SWI/SNF subunits, nei-
ther in puriﬁcations nor in immunoprecipitations at physio-
logical salt concentrations [J. Ryme, P. Asp, and A-K.
O¨stlund Farrants, unpublished results]. We ﬁnd actin re-
cruited to some SWI/SNF-dependent promoters [J. Ryme,
P. Asp and A-K. O¨stlund Farrants, unpublished results]
and it is possible that actin associates transiently with the
SWI/SNF complexes and co-puriﬁes with SWI/SNF com-
plexes under certain conditions. The direct binding of actin
to BRG1 [21] could contribute to actin appearing in some
SWI/SNF preparations. In addition, ARPs have a preference
to bind to actin, and BAF53 could provide another point of
interaction with SWI/SNF complexes. Since actin also binds
to RNA polymerase II [64], it is possible that actin monomers
or polymeric actin forms a bridge between protein complexes
that operate in the proximity of one another. Actin could in
this way provide a platform between transcription initiation,
chromatin remodelling and transcription elongation.
4.3. Actin in INO80 family of chromatin remodelling complexes
The INO80-type complexes have actin and several ARPs
bound in a conserved manner. In yeast, two INO80-type com-plexes have been isolated containing the characteristic split
ATPase domains for INO80-type ATPases: the INO80.com
contains the ATPase INO80 and the SWR1.com contains the
ATPase SWR1 (Swi2/Snf2 related) [1,65]. These complexes
are large multiprotein complexes, comprising 8–14 subunits,
that share many subunits, among these ARPs and actin. The
yeast INO80 complex contains actin and ARP4, ARP5 and
ARP8 [59,65] (Fig. 1). The INO80.com plays a role in tran-
scriptional regulation of speciﬁc genes (such as genes involved
in inositol biosynthesis), in heterochromomatin formation, and
in DNA repair. In DNA repair response, INO80.com is re-
cruited to the break site by nucleosomes with a phosphorylated
H2A, (H2A-c). Phosphorylation of the H2A (or the histone
variant H2AX in mammalian cells) around the break site by
ATM-kinases is an early step in the response to DNA damage.
Two of the ARPs, ARP4 and ARP8, in INO80.com have
nucleosome-binding activity and may help the subunit Nhp1
to recruit the complex INO80.com to the site of DNA breaks
[66,67]. Furthermore, ARP5 and ARP8 function to preserve
the integrity of the complex, and deletions of these proteins
in yeast cause serious defects in the complex assembly [68].
The INO80.com is required for evicting nucleosomes at the
DNA break site at a subsequent step, and this promotes the
formation of single strand DNA ends for the repair machinery,
and at the same time H2A-c is removed [66,69]. Another pos-
sibility is that the chromatin remodelling activity of INO80.-
com is used to replace the H2A variant Htz1p (H2A.Z in
mammalian cells) with H2A, which can in turn be phosphory-
lated and keep the damage response active. Htz1p, which is
loaded into chromatin during G1 and G2 phases, is found in
euchromatin, in particular at inducible promoters and close
to telomeres.
The other INO80 family member present in yeast cells,
SWR1, is a part of a large, 14-subunit, complex, SWR1.com,
which contains actin and ARPs: ARP4 and ARP6 (Fig. 1).
The complex has ATP-dependent histone-exchange activity,
and loads the H2AZ-H2B into chromatin, thereby preventing
heterochromatin regions from spreading along chromosomes
[70,72]. Since euchromatin, in particular promoter regions, is
densely packed with H2AZ-containing nucleosomes, the
SWR1.com has been linked to transcription, but it is also in-
volved in DNA repair. The histone exchange activity of
SWR1.com and the HAT-activity of nucleosome acetyl-trans-
ferase histone 4 (NuA4) are genetically linked [71], suggesting
that a speciﬁc acetylation pattern must be present for the
H2AZ-H2B to be incorporated into chromatin [65]. This has
recently been conﬁrmed, when it was shown that SWR1 re-
quires acetylated histones for its exchange activity [72].
NuA4 is a HAT complex consisting of 13 subunits, and many
of these subunits, such as actin and ARP4, are shared with IN-
O80.com and SWR1.com. Similar to the other two complexes,
NuA4 is involved in the regulation of transcription, in hetero-
chromatin formation, and in DNA repair pathways [66]. In the
repair of DNA double-strand breaks, SWR1.com is recruited
later than INO80.com and it has been proposed that
SWR1.com exchanges histones, possibly H2A-c-H2B, for
H2AZ-H2B in nucleosomes at the damage site [68]. Another
suggestion has been presented by van Attikum et al. [73],
who could not observe an accumulation of Htz1p at damaged
sites, and thus proposed that SWR1.com is required for correct
end-joining and loading of the repair factor Ku80. NuA4 is
also recruited to H2A-c at the site by its ARP4 subunit, and
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has been suggested that NuA4 acetylates H2A-c, giving
SWR1.com the right chromatin environment for exchanging
histones in DNA repair or for the loading of proteins that
are speciﬁc to DNA repair processes [65,67]. In addition to
its role of recruiting complexes to nucleosomes, ARP4 pro-
motes the disassembly of the NuA4 complex to form a smaller
complex, pico-NuA4, and this changes the HAT-activity from
one that is speciﬁc for histone 4 to a general histone acetylation
activity required for transcription [66].
A similar subunit pattern to that found in yeast is present in
complexes puriﬁed from mammalian cells and, to some extent,
from Drosophila: the INO80-containing complex contains
orthologues to most of the yeast subunits, including ARP4
(BAF53), ARP5 and ARP8 [74–76] (Fig. 1). Noteworthy, how-
ever, is the ﬁnding that the ARP4 is not present in the INO80
complex from Drosophila [76]. Actin was not present in the
ﬁrst mammalian preparation [74], but it has recently been
found in a complex aﬃnity-puriﬁed from HeLa cells expressing
Flag-hemagglutinin-tagged YY1, a protein that interacts with
INO80 [75]. The SWR1 ATPase has two orthologues in human
cells, SNF2-related CBP-activating protein (SRCAP) and
p400, and one in Drosophila, Domino. The two mammalian
proteins are found in two separate protein complexes: the
SRCAP protein in the SRCAP complex, which resembles the
yeast SWR1.com [77], and the p400 in the TIP60/TRRAP
complex [78], which is the NuA4 orthologue. The earliest prep-
aration of the SRCAP complex contained BAF53 without ac-
tin [77], but actin was recently co-puriﬁed with the SRCAP
complex in a puriﬁcation using speciﬁc anti-SRCAP antibodies
as the last step [79]. However, the authors raised doubts about
whether actin and other co-puriﬁed proteins, such as diﬀerent
tubulins, are bona ﬁde subunits, since these proteins are often
found in material analysed by mass spectrometry. The
TIP60/TRRAP complex contains both BAF53 and actin [80].
The only SWR1 orthologue in Drosophila, Domino (p400), is
part of the Drosophila HAT TIP60 complex. Drosophila
TIP60 contains both ARP4 (BAP55) and actin [81]. So far,
no orthologue to the mammalian SRCAP has been found in
Drosophila. The SRCAP-speciﬁc ARP6 is present in Drosoph-
ila cells, found associated to heterochromatin, most likely
interacting with heterochromatin protein 1 (HP1) [82]. The
function of these complexes in mammalian and Drosophila
cells is not fully clear. The human INO80 complexes are in-
volved in transcription and DNA repair. INO80 is assembled
at homologous end-joining foci and recruited to double strand
breaks by YY1 [75]. However, INO80 does not co-localise with
foci that have phosphorylated H2AX [75]. The human SRCAP
and the Drosophila TIP60/TRRAP have histone-exchange
activity; in the TIP60/TRRAP complex this activity is com-
bined with the HAT-activity [81]. The human SRCAP loads
H2AZ-H2B into chromatin and is involved in transcription,
as a co-activator for CREB and nuclear receptors [79]. The
Drosophila TIP60 exchanges phosphorylated H2Av (which
possesses both the ability to be phosphorylated in response
to DNA damage and the characteristics of H2AZ of being
present in euchromatin) for unmodiﬁed H2Av [81]. Both the
mammalian and the Drosophila TIP60/TRRAP are linked to
transcription and DNA repair [71,77,80,83]. In DNA repair,
these complexes are recruited to breaks by H2A-c at the
DNA-damage site, and subsequently involved in the removal
of the H2A-c. Two mechanisms have been proposed in humancells: in the early response, the HAT-activity of TIP60/TRRAP
acetylates H2A-c, which becomes polyubiquinylated and ex-
changed [81,82]. Later in the response, TIP60/TRRAP acety-
lates histone 4 in nucleosomes containing H2A-c, promoting
dephosphorylation, most probably by a prior histone exchange
mechanism [84]. The acetylation of phospho-H2Av prior to ex-
change occurs in relation to the action of the Drosophila TIP60
complex [81]. The function of actin in these complexes is still
unclear, but it may bind ARPs, stabilise complexes and pro-
vide binding surfaces for chromatin, other subunits, and inter-
acting factors. Polymeric forms of actin have not been found in
chromatin remodelling complexes, and actin is present in sto-
ichiometrical or sub-stoichiometrical amounts (as are the
ARPs) [21].5. Concluding remarks and future perspectives
ATP-dependent chromatin remodelling is an event that
inﬂuences gene expression at a global level, and other nuclear
processes. SWI/SNF complexes aﬀect the cellular architecture,
which is determined by the actin ﬁlament system, most proba-
bly by altering the expression of cell adhesion proteins and sig-
nal transduction proteins. It cannot be ruled out, however,
that SWI/SNF complexes are also involved in the MAL–
SRF regulation of the actin ﬁlament dynamics, regulating actin
cytoskeletal genes. SWI/SNF is involved in the MAL–SRF
induction of smooth muscle during smooth muscle diﬀerentia-
tion, in a process in which MAL interacts directly with BRG1.
It is still unclear what determines that SWI/SNF complexes are
recruited to one type of MAL–SRF. Possible future work is
the study of the eﬀect of actin binding to MAL on MAL–
SRF complexes at the promoter at the diﬀerent kinds of
MAL–SRF genes. SWI/SNF complexes are also required for
GATA-SRF mediated induction of smooth muscle speciﬁc
genes during cardiac diﬀerentiation, together with the bridging
factor LIM-only protein CRP2. In addition, actin and ARPs
are subunits in chromatin remodelling complexes, and the
SWI/SNF subunit BRG1 binds to actin directly in two ways:
one of these depends on phosphoinositol, the other does not.
The ratio of actin to other subunits does not exceed 1:1, sug-
gesting that monomeric actin is associated with the SWI/
SNF complexes or other complexes. However, the association
of actin with SWI/SNF complexes is not clear (it is, for exam-
ple, not found in all puriﬁed complexes), and should be inves-
tigated further. One possible explanation for the uncertainty of
whether actin is present in SWI/SNF complexes is that the
binding corresponds to actin dynamics, and thereby reﬂects
the actin status of the cell or the phosphoinositol signalling sta-
tus. It is generally accepted that actin and ARP are important
components in INO80-type complexes and in the HAT NuA4/
TIP60, even though actin is not always present in preparations
of the mammalian orthologous complexes.
One important issue for future research is the form, mono-
meric or polymeric, that actin has in the nucleus and in the dif-
ferent nuclear processes. Short, dynamic actin ﬁlaments are
present in the nucleus, and it has been suggested that these
function in transcription recently reviewed in [85]. The stoichi-
ometry in chromatin remodelling complexes suggests that the
form is monomeric, most likely bridging diﬀerent subunits or
proteins at the site. The ﬁnding that short actin ﬁlaments, to-
gether with NM1, act as an actomyosin-like driving force in
2048 A.-K.O¨. Farrants / FEBS Letters 582 (2008) 2041–2050RNA polymerase I transcription raises questions about the
role of actin in other nuclear processes. Do RNA polymerase
II and III also use actin-myosin motors during elongation
(NM1 is not present on all genes), and what are the roles of
the RNA polymerases themselves? Other questions concern
the role of actin in chromatin remodelling complexes and
whether these complexes can also bind ﬁlamentous actin.
Can they anchor proteins, such as the RNA polymerases, to
chromatin in this way?
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